BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18215400)

  • 1. The cerebellum in mild cognitive impairment and Alzheimer's disease - a structural MRI study.
    Thomann PA; Schläfer C; Seidl U; Santos VD; Essig M; Schröder J
    J Psychiatr Res; 2008 Oct; 42(14):1198-202. PubMed ID: 18215400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cerebellum shrinks faster than normal ageing in Alzheimer's disease but not in mild cognitive impairment.
    Tabatabaei-Jafari H; Walsh E; Shaw ME; Cherbuin N;
    Hum Brain Mapp; 2017 Jun; 38(6):3141-3150. PubMed ID: 28321950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimer's disease.
    Choo IH; Lee DY; Oh JS; Lee JS; Lee DS; Song IC; Youn JC; Kim SG; Kim KW; Jhoo JH; Woo JI
    Neurobiol Aging; 2010 May; 31(5):772-9. PubMed ID: 18687503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological cerebral correlates of CERAD test performance in mild cognitive impairment and Alzheimer's disease.
    Dos Santos V; Thomann PA; Wüstenberg T; Seidl U; Essig M; Schröder J
    J Alzheimers Dis; 2011; 23(3):411-20. PubMed ID: 21116054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints.
    Wang PJ; Saykin AJ; Flashman LA; Wishart HA; Rabin LA; Santulli RB; McHugh TL; MacDonald JW; Mamourian AC
    Neurobiol Aging; 2006 Nov; 27(11):1613-7. PubMed ID: 16271806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-derived atrophy of the olfactory bulb and tract in mild cognitive impairment and Alzheimer's disease.
    Thomann PA; Dos Santos V; Seidl U; Toro P; Essig M; Schröder J
    J Alzheimers Dis; 2009; 17(1):213-21. PubMed ID: 19494444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion tensor imaging of normal appearing white matter and its correlation with cognitive functioning in mild cognitive impairment and Alzheimer's disease.
    Huang J; Auchus AP
    Ann N Y Acad Sci; 2007 Feb; 1097():259-64. PubMed ID: 17413027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between cerebellar and brain volumes, cognitive impairments, ApoE levels, and APOE genotypes in patients with AD and MCI.
    Łojkowska W; Witkowski G; Bednarska-Makaruk M; Wehr H; Sienkiewicz-Jarosz H; Graban A; Bochyńska A; Wiśniewska A; Gugała M; Sławińska K; Sawicka B; Poniatowska R; Ryglewicz D
    Curr Alzheimer Res; 2013 Nov; 10(9):964-72. PubMed ID: 24117117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural changes of the corpus callosum in mild cognitive impairment and Alzheimer's disease.
    Thomann PA; Wustenberg T; Pantel J; Essig M; Schroder J
    Dement Geriatr Cogn Disord; 2006; 21(4):215-20. PubMed ID: 16415572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Callosal atrophy in mild cognitive impairment and Alzheimer's disease: different effects in different stages.
    Di Paola M; Luders E; Di Iulio F; Cherubini A; Passafiume D; Thompson PM; Caltagirone C; Toga AW; Spalletta G
    Neuroimage; 2010 Jan; 49(1):141-9. PubMed ID: 19643188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
    Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
    Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study.
    Di Paola M; Di Iulio F; Cherubini A; Blundo C; Casini AR; Sancesario G; Passafiume D; Caltagirone C; Spalletta G
    Neurology; 2010 Apr; 74(14):1136-42. PubMed ID: 20368633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.
    Liu Y; Paajanen T; Zhang Y; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    Neurobiol Aging; 2010 Aug; 31(8):1375-85. PubMed ID: 20447732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease.
    Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar substructures and neurological soft signs in first-episode schizophrenia.
    Thomann PA; Roebel M; Dos Santos V; Bachmann S; Essig M; Schröder J
    Psychiatry Res; 2009 Aug; 173(2):83-7. PubMed ID: 19540731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia.
    Luckhaus C; Cohnen M; Flüss MO; Jänner M; Grass-Kapanke B; Teipel SJ; Grothe M; Hampel H; Peters O; Kornhuber J; Maier W; Supprian T; Gaebel W; Mödder U; Wittsack HJ
    Psychiatry Res; 2010 Jul; 183(1):44-51. PubMed ID: 20541374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corpus callosum atrophy in patients with mild Alzheimer's disease.
    Frederiksen KS; Garde E; Skimminge A; Ryberg C; Rostrup E; Baaré WF; Siebner HR; Hejl AM; Leffers AM; Waldemar G
    Neurodegener Dis; 2011; 8(6):476-82. PubMed ID: 21659724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clock drawing performance and brain morphology in mild cognitive impairment and Alzheimer's disease.
    Thomann PA; Toro P; Dos Santos V; Essig M; Schröder J
    Brain Cogn; 2008 Jun; 67(1):88-93. PubMed ID: 18215449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical changes in incipient Alzheimer's disease.
    Prestia A; Drago V; Rasser PE; Bonetti M; Thompson PM; Frisoni GB
    J Alzheimers Dis; 2010; 22(4):1339-49. PubMed ID: 20930288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Chen YF; Wang H; Chu Y; Huang YC; Su MY
    Dement Geriatr Cogn Disord; 2006; 22(2):177-84. PubMed ID: 16912479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.